PubRank

Z A Arlin

Author PubWeight™ 30.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis. J Exp Med 1986 1.60
2 Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia. Blood 1992 1.46
3 Leukemia following treatment of germ cell tumors in men. J Clin Oncol 1984 1.01
4 The acute monocytic leukemias: multidisciplinary studies in 45 patients. Medicine (Baltimore) 1980 0.99
5 Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia. Leukemia 1996 0.98
6 Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia (CML) following a chemotherapy-induced loss of the Ph1 chromosome. Blood 1980 0.91
7 A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia. Semin Oncol 1989 0.90
8 Therapeutic role of cell kinetics in acute leukaemia. Clin Haematol 1978 0.87
9 Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia. Cancer Treat Rep 1982 0.87
10 Delineation of the development of T lymphocytes from leukemic null lymphocytes upon induction by conditioned medium. Cell Immunol 1980 0.87
11 Current status of amsacrine (AMSA) combination chemotherapy programs in acute leukemia. Cancer Treat Rep 1983 0.86
12 Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols. J Clin Oncol 1983 0.85
13 Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia. Cancer Res 1985 0.84
14 Chronic myelogenous leukemia in the monosomic cell line of a fertile Turner syndrome mosaic (45,X/46,XX). Cancer Genet Cytogenet 1982 0.84
15 Hairy cell leukemia. Durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patients. Cancer 1985 0.83
16 A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia. J Clin Oncol 1991 0.82
17 Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase--positive acute leukemia. Blood 1978 0.82
18 Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol. Leukemia 1989 0.81
19 Nonclonal hemopoietic progenitor cells detected in long-term marrow cultures from a Turner syndrome mosaic with chronic myeloid leukemia. Blood 1984 0.81
20 Leukemic dermal infiltrates at permanent indwelling central venous catheter insertion sites. Cancer 1991 0.80
21 Chronic myelogenous leukemia: in vitro studies of hematopoietic regulation in a patient undergoing intensive chemotherapy. J Clin Invest 1981 0.79
22 "Polymyositis"-like syndrome resulting from hypothyroidism in a patient with a nodular lymphoma. Clin Bull 1981 0.78
23 Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 1989 0.78
24 Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia. Cancer Treat Rep 1982 0.78
25 Cytofluorometric studies on conformation of nucleic acids in situ. II. Denaturation of deoxyribonucleic acid. J Histochem Cytochem 1976 0.78
26 Phase I-II trial of mitoxantrone in acute leukemia. Cancer Treat Rep 1985 0.78
27 High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease. Leukemia 1989 0.77
28 A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia. Semin Oncol 1992 0.77
29 Patients with secondary acute myelocytic leukemia (AML) receiving "timed" sequential chemotherapy. J Clin Oncol 1983 0.76
30 Association of helper activity for B-lymphocyte differentiation with lymphocytes having both SRBC and complement receptors in a patient with lymphoproliferative disease. Clin Immunol Immunopathol 1979 0.76
31 4-demethoxydaunorubicin (idarubicin) in combination with 1-beta-D-arabinofuranosylcytosine in the treatment of relapsed or refractory acute leukemia. Cancer Res 1989 0.76
32 Acute promyelocytic leukemia: a 5-year experience with new antileukemic agents and a new approach to preventing fatal hemorrhage. Acta Haematol 1989 0.75
33 Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia. Cancer Res 1980 0.75
34 Human immunodeficiency virus infections: considerations for health care workers. Bull N Y Acad Med 1988 0.75
35 Treatment of DIC associated with APL. Blood 1990 0.75
36 Treatment of acute promyelocytic leukemia. Blood 1992 0.75
37 Amsacrine retains a special role supporting Food and Drug Administration approval. J Clin Oncol 1992 0.75
38 Treatment of patients with advanced cancer using multiple long-term cultured lymphokine-activated killer (LAK) cell infusions and recombinant human interleukin-2. J Biol Response Mod 1989 0.75
39 The treatment of acute nonlymphoblastic leukemia in adults. Adv Intern Med 1983 0.75
40 The psychodynamics of multiple remissions in a patient with acute nonlymphoblastic leukemia. Cancer Nurs 1983 0.75
41 Chronic lymphocytic leukemia in a bisexual male. Cancer Invest 1983 0.75
42 Evaluating new drugs: a three-step approach. J Clin Oncol 1986 0.75
43 Clustering of non-Hodgkin's lymphomas. A case study. Am J Med 1984 0.75
44 Selective alopecia with mitoxantrone. N Engl J Med 1984 0.75
45 Combination amsacrine and high-dose cytosine arabinoside in acute leukemia. J Clin Oncol 1985 0.75
46 Guidelines for infection with the human immunodeficiency virus (HIV) and health care workers. Ann Intern Med 1988 0.75
47 Chronic myelogenous leukemia in an XYY male. Cancer Genet Cytogenet 1982 0.75
48 Modern management of chronic myelogenous leukemia (CML). Cancer Invest 1988 0.75
49 Treatment of refractory adult lymphoblastic leukemia (ALL) with 4'(9-acridinylamino) methanesulfon-M-anisidide (AMSA). Blood 1982 0.75
50 13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemia. J Clin Oncol 1985 0.75
51 Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine. Cancer Clin Trials 1981 0.75
52 Treatment of acute leukemia with amsacrine and high-dose cytarabine. Cancer Treat Rep 1985 0.75
53 Treatment of blastic transformation of chronic myelogenous leukemia with mitoxantrone. Cancer Chemother Pharmacol 1986 0.75
54 A monocytic leukemoid reaction: a manifestation of preleukemia. R I Med J 1985 0.75
55 Amsacrine is safe in patients with ventricular ectopy. Am J Hematol 1988 0.75
56 Treatment of acute promyelocytic leukemia. Blood 1989 0.75
57 AMSA-induced seizures in patients with hypokalemia. Cancer Treat Rep 1983 0.75
58 Allergic reaction following administration of AMSA. Cancer Treat Rep 1981 0.75
59 Amsacrine administration: a precautionary note. Cancer Chemother Pharmacol 1984 0.75
60 Phase I-II trial of mitoxantrone in acute leukemia: an interim report. Invest New Drugs 1985 0.75
61 Bone marrow transplantation for chronic myelogenous leukemia: some thoughts about future prospects. Leukemia 1988 0.75
62 Philadelphia chromosome mosaicism in chronic granulocytic leukemia. J Clin Oncol 1986 0.75
63 Current status of treatment of acute leukemia in adults: an overview of the Memorial experience and review of literature. Crit Rev Oncol Hematol 1986 0.75
64 Incidence and treatment of tumor lysis syndrome in patients with acute leukemia. Acta Haematol 1994 0.75
65 Successful treatment of a patient with acute nonlymphoblastic leukemia (ANLL) and anthracycline cardiomyopathy with 4' (9-acridinylamino) methanesulfon-m-anisidide (AMSA). Cancer Chemother Pharmacol 1982 0.75
66 Vincristine and Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med 1984 0.75
67 High-dose cytosine arabinoside with amsacrine for treatment of acute lymphoblastic leukemia. J Clin Oncol 1986 0.75
68 Preventing amsacrine-induced cardiac arrhythmias. J Clin Oncol 1987 0.75
69 Improving the "quality of remission induction" therapy: a necessary step for increasing the cure rate in acute myelogenous leukemia. Cancer Invest 1992 0.75
70 Relationship of a T-lymphocyte marker to phase of cell cycle and morphology of leukemic cells. Cancer 1977 0.75
71 Pseudo-Philadelphia-positive acute lymphoblastic leukemia (Ph1 + ALL) J Clin Oncol 1987 0.75
72 Autologous and allogeneic bone marrow transplantation. N Y State J Med 1986 0.75
73 Authorship and clinical trials. Ann Intern Med 1988 0.75
74 Induction of remission in acute promyelocytic leukemia with mitoxantrone. Cancer Chemother Pharmacol 1985 0.75
75 Cure in acute promyelocytic leukemia: now more readily achievable with less toxic therapy. Blood 1992 0.75
76 A new regimen of amsacrine with high-dose cytarabine is safe and effective therapy for acute leukemia. J Clin Oncol 1987 0.75